Introduction
Brain injuries such as neurotrauma, febrile seizures, infections or status epilepticus induce inflammatory responses and this in turn can be associated with acute symptomatic seizures and a high risk of developing chronic epilepsy. 1, 2 In human patients only little is known about differential expression of inflammatory factors in correlation to seizure frequency and other clinical parameters. In this context, we have focused on the key human inflammatory mediators, toll-like receptor 4 (TLR4), ATF-3 and IL8, for the following reasons: TLR4 has previously been shown as key trigger of inflammation by inducing the gene transcription of several cytokines and contribute to seizure formation and severity in a TLE animal model. 3 In kainate-induced epileptic mice and in
Purpose:
Data from animal models has nicely shown that inflammatory processes in the central nervous system (CNS) can modulate seizure frequency. However, a potential relationship between the modulation of seizure frequency and gene expression of key inflammatory factors in human epileptic tissue is still unresolved. 7 and an association of intrathecal IL8 synthesis and seizure frequency has been reported. 8 Furthermore, ATF-3 impacts the expression of chemokines. 9 Here, we have used our unique access to human epileptic brain tissue from epilepsy surgery in order to investigate the role of these key mediators of inflammatory processes in correlation to seizure frequency.
Materials and methods
We used human bioptic brain tissue to analyze the gene expression data in correlation to the seizure frequency from patients (n = 26) with chronic pharmacoresistant mTLE, 10 who underwent surgical treatment in the Epilepsy Surgery Program at the University of Bonn Medical Center. The patient group under study (n = 26 Caucasians) is particularly well characterized with respect to seizure documentation and represents substantial differences in seizure frequency (Supplemental Table 1 ). In all patients, presurgical evaluation using a combination of noninvasive and invasive procedures revealed that seizures originated in the mesial temporal lobe. ; n = 23). Different n-numbers for the individual genes are due to the fact that expression values that were ''not detectable'' had to be omitted from the analysis. whole hippocampus and variable seizure frequency were done by the Pearson product moment correlation (r) and the correlation ttest (p) using the statistical language R.
Results and discussion
We investigated the expression and distribution of the key inflammatory mediators TLR4, ATF-3 and IL8 in human hippocampal tissue and a potential correlation of seizure frequency and expression of respective genes. We observed that abundant TLR4 expression correlated significantly with high seizure frequency (Pearson correlation coefficient: r = 0.407; two-tailed t-test: p = 0.047; n = 24; Fig. 1A) . For ATF-3 we found that patients with high seizure frequency show low levels of gene expression (r = À0.431; two-tailed t-test: p = 0.027; n = 26; Fig. 1B) . The minor ATF-3 expression and abundant TLR4 expression in patients with high seizure frequency may support the role of ATF-3 as a negative regulator of TLR4 signaling in human epileptic hippocampi. 4 Furthermore, ATF-3 has been suggested as a regulator of chemokine expression. 9 Low expression of the human specific IL8
chemokine is significantly correlated with high seizure frequency (r = À0.671; two-tailed t-test: p = 1.7 Â 10 À04 ; n = 23; Fig. 1C ). Intriguingly, in our present analyses the human-specific inflammatory mediator IL8 showed the most significant correlation of gene expression and seizure frequency in human epileptic brain tissue. Particularly, these data may underline the need for analyses in human epileptic tissue complementary to animal models, where these analyses for obvious reasons are not possible. In order to address co-correlation of the reported associations of gene expression levels with other clinical parameters, we carried out a comprehensive co-variance analysis of clinical and therapeutic data of the patients included here (Supplemental Table 2 ). These analyses did not result in significant associations of TLR4, ATF-3 and IL8 mRNA expression with any of the additional individual parameters investigated. Complementarily, we examined potential inter-correlations among the three inflammatory mediator expression levels based on the seizure frequency. To this end, we performed a one-way MANOVA to test for comprehensive expression dynamics of the inflammatory mediators under study. One-way MANOVA revealed a significant multivariate main effect in the expression of inflammatory mediators based on seizure frequency (Pillai's trace statistic = 2.281, F(45, 27) = 1.905, p = 0.039). Power to detect the effect was 0.943 (Supplemental Table 3 ).
Recent studies in hippocampal tissue of pharmacoresistant mTLE patients with hippocampal sclerosis indicated TLR4 expression in pyramidal neurons and GFAP-positive astrocytes. 3 We found consistent expression patterns in pharmacoresistant mTLE patients by immunohistochemical reactions with antibodies against GFAP and NeuN ( Fig. 2A) . We did not observe TLR4 expression in microglia (data not shown). The presence of TLR4 in neurons and reactive astrocytes in human epileptic tissue and the increased expression in patients with high seizure frequency may underline a potential modifying role of TLR4 for seizure frequency in human epilepsy. Previous data suggested expression of ATF-3 in nuclei of dentate gyrus granule cells after kainate induced epilepsy.
14 Glial cells as well as reactive astrocytes lacked ATF-3 expression. 15 By double immunofluorescence, we here observed ATF-3 expression in neurons expressing NeuN in paraffin sections of human hippocampal tissue (NeuN, Fig. 2B ). Expression of ATF-3 protein was neither detected in glial components such as reactive astrocytes (data not shown) nor in microglia components (data not shown). In contrast, the chemokine IL8 has been described to be produced exclusively by microglial cells and astrocytes. 7 We performed double-immunofluorescence analyses using antibodies directed against HLA-DR and GFAP to investigate the expression of IL8 in human hippocampal brain tissue. We found IL8 as expressed in both, microglia and reactive astrocytes (Fig. 2C) . However, IL8 revealed no co-expression with the neuronal marker NeuN (data not shown).
Our results suggest a substantial correlation between gene expression of inflammatory key mediators and seizure frequency in epileptic patients. Considering the fact that factors under study are differentially expressed in pharmacoresistant mTLE hippocampi, pharmacological interference with such cascades may provide new vistas of anticonvulsive therapy in the future.
